Evidence map›Paper›PMID 41333613›Full record

SynthesisTransboundary and emerging diseases2025

Mapping the Global Distribution of

Bo-Kang Fu, Tian Tang, Ming Yue, Jin-Jin Chen, Hong Su, Xiao-Bin Huang, Yu-Feng Yang, Simon I Hay, Li-Qun Fang, Wei Liu

Abstract readSystematic Review
In one paragraph

Synthesis in Transboundary and emerging diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. A Comprehensive Molecular Survey ofVeterinary sciences · 2026
    Article
  2. Article
  3. Article
  4. Tafenoquine: A Breakthrough Option for Babesiosis Treatment.Tropical medicine and infectious disease · 2026
    Article
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Bo-Kang FuSchool of Public Health, Anhui Medical University, Hefei 230022, China.ORCID https://orcid.org/0009-0007-6566-1749
Tian TangState Key Laboratory of Pathogen and Biosecurity, Academy of Military Medical Science, Beijing 100071, China.ORCID https://orcid.org/0009-0001-7450-3853
Ming YueDepartment of Infectious Diseases, The First Affiliated Hospital with Nanjing Medical University, Nanjing 210029, China.ORCID https://orcid.org/0000-0002-7677-0832
Jin-Jin ChenState Key Laboratory of Pathogen and Biosecurity, Academy of Military Medical Science, Beijing 100071, China.ORCID https://orcid.org/0000-0002-8058-8013
Hong SuSchool of Public Health, Anhui Medical University, Hefei 230022, China.ORCID https://orcid.org/0000-0002-4673-6449
Xiao-Bin HuangState Key Laboratory of Pathogen and Biosecurity, Academy of Military Medical Science, Beijing 100071, China.ORCID https://orcid.org/0009-0008-1700-0978
Yu-Feng YangSchool of Public Health, Anhui Medical University, Hefei 230022, China.ORCID https://orcid.org/0009-0002-4865-5949
Simon I HayDepartment of Health Metrics Sciences, School of Medicine, University of Washington, Seattle, Washington, USA.ORCID https://orcid.org/0000-0002-0611-7272
Li-Qun FangSchool of Public Health, Anhui Medical University, Hefei 230022, China.ORCID https://orcid.org/0000-0002-4981-1483
Wei LiuSchool of Public Health, Anhui Medical University, Hefei 230022, China.ORCID https://orcid.org/0009-0001-6937-2430

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Understanding the ecological niches and quantifying the disease burden of

Indexed as

BabesiaBabesiosisAnimalsGlobal HealthHumansTicks

Identifiers

PMID41333613
PMCPMC12668841

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.